LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 3 of total 3

Search options

  1. Article ; Online: Acridine Based N -Acylhydrazone Derivatives as Potential Anticancer Agents

    Mária Vilková / Monika Hudáčová / Nikola Palušeková / Rastislav Jendželovský / Miroslav Almáši / Tibor Béres / Peter Fedoročko / Mária Kožurková

    Molecules, Vol 27, Iss 2883, p

    Synthesis, Characterization and ctDNA/HSA Spectroscopic Binding Properties

    2022  Volume 2883

    Abstract: A series of novel acridine N -acylhydrazone derivatives have been synthesized as potential topoisomerase I/II inhibitors, and their binding (calf thymus DNA—ctDNA and human serum albumin—HSA) and biological activities as potential anticancer agents on ... ...

    Abstract A series of novel acridine N -acylhydrazone derivatives have been synthesized as potential topoisomerase I/II inhibitors, and their binding (calf thymus DNA—ctDNA and human serum albumin—HSA) and biological activities as potential anticancer agents on proliferation of A549 and CCD-18Co have been evaluated. The acridine-DNA complex 3b (-F) displayed the highest K b value ( K b = 3.18 × 10 3 M −1 ). The HSA-derivatives interactions were studied by fluorescence quenching spectra. This method was used for the calculation of characteristic binding parameters. In the presence of warfarin, the binding constant values were found to decrease (K SV = 2.26 M −1 , K b = 2.54 M −1 ), suggesting that derivative 3a could bind to HSA at Sudlow site I. The effect of tested derivatives on metabolic activity of A549 cells evaluated by the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide or MTT assay decreased as follows 3b (-F) > 3a (-H) > 3c (-Cl) > 3d (-Br). The derivatives 3c and 3d in vitro act as potential dual inhibitors of hTopo I and II with a partial effect on the metabolic activity of cancer cells A594. The acridine-benzohydrazides 3a and 3c reduced the clonogenic ability of A549 cells by 72% or 74%, respectively. The general results of the study suggest that the novel compounds show potential for future development as anticancer agents.
    Keywords acridine ; benzohydrazide ; ctDNA ; HSA binding ; spectroscopic study ; Organic chemistry ; QD241-441
    Subject code 333
    Language English
    Publishing date 2022-04-01T00:00:00Z
    Publisher MDPI AG
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  2. Article ; Online: Tacrine-Coumarin Derivatives as Topoisomerase Inhibitors with Antitumor Effects on A549 Human Lung Carcinoma Cancer Cell Lines

    Eva Konkoľová / Monika Hudáčová / Slávka Hamuľaková / Rastislav Jendželovský / Jana Vargová / Juraj Ševc / Peter Fedoročko / Mária Kožurková

    Molecules, Vol 26, Iss 4, p

    2021  Volume 1133

    Abstract: A549 human lung carcinoma cell lines were treated with a series of new drugs with both tacrine and coumarin pharmacophores (derivatives 1a – 2c ) in order to test the compounds’ ability to inhibit both cancer cell growth and topoisomerase I and II ... ...

    Abstract A549 human lung carcinoma cell lines were treated with a series of new drugs with both tacrine and coumarin pharmacophores (derivatives 1a – 2c ) in order to test the compounds’ ability to inhibit both cancer cell growth and topoisomerase I and II activity. The ability of human topoisomerase I ( h TOPI) and II to relax supercoiled plasmid DNA in the presence of various concentrations of the tacrine-coumarin hybrid molecules was studied with agarose gel electrophoresis. The biological activities of the derivatives were studied using MTT assays, clonogenic assays, cell cycle analysis and quantification of cell number and viability. The content and localization of the derivatives in the cells were analysed using flow cytometry and confocal microscopy. All of the studied compounds were found to have inhibited topoisomerase I activity completely. The effect of the tacrine-coumarin hybrid compounds on cancer cells is likely to be dependent on the length of the chain between the tacrine and coumarin moieties ( 1c , 1d = tacrine-(CH 2 ) 8–9 -coumarin). The most active of the tested compounds, derivatives 1c and 1d , both display longer chains.
    Keywords tacrine-coumarin derivatives ; DNA ; topoisomerases I ; II ; cytotoxicity ; lung carcinoma cells ; A549 ; Organic chemistry ; QD241-441
    Subject code 540
    Language English
    Publishing date 2021-02-01T00:00:00Z
    Publisher MDPI AG
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  3. Article ; Online: Synthesis of New Biscoumarin Derivatives, In Vitro Cholinesterase Inhibition, Molecular Modelling and Antiproliferative Effect in A549 Human Lung Carcinoma Cells

    Monika Hudáčová / Slávka Hamuľaková / Eva Konkoľová / Rastislav Jendželovský / Jana Vargová / Juraj Ševc / Peter Fedoročko / Ondrej Soukup / Jana Janočková / Veronika Ihnatova / Tomáš Kučera / Petr Bzonek / Nikola Novakova / Daniel Jun / Lucie Junova / Jan Korábečný / Kamil Kuča / Mária Kožurková

    International Journal of Molecular Sciences, Vol 22, Iss 3830, p

    2021  Volume 3830

    Abstract: A series of novel C4-C7-tethered biscoumarin derivatives ( 12a – e ) linked through piperazine moiety was designed, synthesized, and evaluated biological/therapeutic potential. Biscoumarin 12d was found to be the most effective inhibitor of both ... ...

    Abstract A series of novel C4-C7-tethered biscoumarin derivatives ( 12a – e ) linked through piperazine moiety was designed, synthesized, and evaluated biological/therapeutic potential. Biscoumarin 12d was found to be the most effective inhibitor of both acetylcholinesterase (AChE, IC 50 = 6.30 µM) and butyrylcholinesterase (BChE, IC 50 = 49 µM). Detailed molecular modelling studies compared the accommodation of ensaculin (well-established coumarin derivative tested in phase I of clinical trials) and 12d in the human recombinant AChE ( h AChE) active site. The ability of novel compounds to cross the blood–brain barrier (BBB) was predicted with a positive outcome for compound 12e . The antiproliferative effects of newly synthesized biscoumarin derivatives were tested in vitro on human lung carcinoma cell line (A549) and normal colon fibroblast cell line (CCD-18Co). The effect of derivatives on cell proliferation was evaluated by MTT assay, quantification of cell numbers and viability, colony-forming assay, analysis of cell cycle distribution and mitotic activity. Intracellular localization of used derivatives in A549 cells was confirmed by confocal microscopy. Derivatives 12d and 12e showed significant antiproliferative activity in A549 cancer cells without a significant effect on normal CCD-18Co cells. The inhibition of h AChE/human recombinant BChE ( h BChE), the antiproliferative activity on cancer cells, and the ability to cross the BBB suggest the high potential of biscoumarin derivatives. Beside the treatment of cancer, 12e might be applicable against disorders such as schizophrenia, and 12d could serve future development as therapeutic agents in the prevention and/or treatment of Alzheimer’s disease.
    Keywords biscoumarin ; Alzheimer’s disease ; blood–brain barrier ; cholinesterase ; antiproliferative activity ; A549 ; Biology (General) ; QH301-705.5 ; Chemistry ; QD1-999
    Subject code 610
    Language English
    Publishing date 2021-04-01T00:00:00Z
    Publisher MDPI AG
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

To top